JP2022524993A5 - - Google Patents
Info
- Publication number
- JP2022524993A5 JP2022524993A5 JP2021552604A JP2021552604A JP2022524993A5 JP 2022524993 A5 JP2022524993 A5 JP 2022524993A5 JP 2021552604 A JP2021552604 A JP 2021552604A JP 2021552604 A JP2021552604 A JP 2021552604A JP 2022524993 A5 JP2022524993 A5 JP 2022524993A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- tcr
- acid sequence
- hla
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025011527A JP7825752B2 (ja) | 2019-03-04 | 2025-01-27 | Ｔ細胞受容体及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962813647P | 2019-03-04 | 2019-03-04 | |
| US62/813,647 | 2019-03-04 | ||
| PCT/IB2020/051811 WO2020178742A1 (en) | 2019-03-04 | 2020-03-03 | T cell receptors and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025011527A Division JP7825752B2 (ja) | 2019-03-04 | 2025-01-27 | Ｔ細胞受容体及びその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022524993A JP2022524993A (ja) | 2022-05-11 |
| JP2022524993A5 true JP2022524993A5 (enExample) | 2023-03-13 |
Family
ID=72337382
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552604A Withdrawn JP2022524993A (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
| JP2025011527A Active JP7825752B2 (ja) | 2019-03-04 | 2025-01-27 | Ｔ細胞受容体及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025011527A Active JP7825752B2 (ja) | 2019-03-04 | 2025-01-27 | Ｔ細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220152105A1 (enExample) |
| EP (1) | EP3935177A4 (enExample) |
| JP (2) | JP2022524993A (enExample) |
| KR (1) | KR20210144740A (enExample) |
| CN (1) | CN113795585B (enExample) |
| AU (1) | AU2020231107A1 (enExample) |
| BR (1) | BR112021017467A2 (enExample) |
| CA (1) | CA3132434A1 (enExample) |
| IL (1) | IL286041A (enExample) |
| MX (1) | MX2021010539A (enExample) |
| SG (1) | SG11202109593SA (enExample) |
| TW (1) | TWI877144B (enExample) |
| WO (1) | WO2020178742A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240007775A (ko) | 2016-12-08 | 2024-01-16 | 이매틱스 바이오테크놀로지스 게엠베하 | T 세포 수용체 및 이를 사용하는 면역 요법 |
| EP3935175A4 (en) | 2019-03-04 | 2023-01-04 | University Health Network | T-LYMPHOCYTE RECEPTORS AND METHODS OF USE THEREOF |
| CN113795584B (zh) | 2019-03-04 | 2025-09-30 | 大学健康网络 | T细胞受体及其使用方法 |
| KR20210144737A (ko) | 2019-03-04 | 2021-11-30 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
| MX2021011462A (es) | 2019-03-25 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de los mismos. |
| CN112239495B (zh) * | 2020-10-29 | 2022-04-12 | 上海药明生物技术有限公司 | 稳定的tcr结构及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008089053A2 (en) * | 2007-01-12 | 2008-07-24 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Gp100-specific t cell receptors and related materials and methods of use |
| KR101363928B1 (ko) * | 2007-06-11 | 2014-02-19 | 고쿠리츠다이가쿠호진 미에다이가쿠 | 특이적 유전자 발현 방법 |
| EP2337795A2 (en) * | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| WO2017185169A1 (en) * | 2016-04-27 | 2017-11-02 | University Health Network (Uhn) | Pept1de-hla complexes and methods of producing same |
-
2020
- 2020-03-03 KR KR1020217031553A patent/KR20210144740A/ko active Pending
- 2020-03-03 US US17/436,936 patent/US20220152105A1/en active Pending
- 2020-03-03 CA CA3132434A patent/CA3132434A1/en active Pending
- 2020-03-03 BR BR112021017467A patent/BR112021017467A2/pt unknown
- 2020-03-03 EP EP20767178.5A patent/EP3935177A4/en active Pending
- 2020-03-03 AU AU2020231107A patent/AU2020231107A1/en active Pending
- 2020-03-03 SG SG11202109593S patent/SG11202109593SA/en unknown
- 2020-03-03 MX MX2021010539A patent/MX2021010539A/es unknown
- 2020-03-03 WO PCT/IB2020/051811 patent/WO2020178742A1/en not_active Ceased
- 2020-03-03 JP JP2021552604A patent/JP2022524993A/ja not_active Withdrawn
- 2020-03-03 CN CN202080025290.9A patent/CN113795585B/zh active Active
- 2020-03-04 TW TW109107110A patent/TWI877144B/zh active
-
2021
- 2021-09-01 IL IL286041A patent/IL286041A/en unknown
-
2025
- 2025-01-27 JP JP2025011527A patent/JP7825752B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527267A5 (enExample) | ||
| JP2022523554A5 (enExample) | ||
| JP2022524993A5 (enExample) | ||
| JP2022524994A5 (enExample) | ||
| JP2022523552A5 (enExample) | ||
| JP2022523971A5 (enExample) | ||
| JP2022523553A5 (enExample) | ||
| JP2022524992A5 (enExample) | ||
| Batlevi et al. | Novel immunotherapies in lymphoid malignancies | |
| Baxevanis et al. | Cancer immunotherapy | |
| EP2446897A1 (en) | Anti-KIR combination treatments and methods | |
| Shilyansky et al. | T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. | |
| Tsang et al. | Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. | |
| KR102723492B1 (ko) | 생체내 지속성 및 치료학적 활성 및 이의 증식을 위한 nkt-세포 서브세트 | |
| US20170232070A1 (en) | Combination Methods for Immunotherapy | |
| Junghans | The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective | |
| US11951131B2 (en) | Anti-SLAMF7 chimeric antigen receptors | |
| CN113785065B (zh) | T细胞受体及其使用方法 | |
| JP2022543059A5 (enExample) | ||
| JP2020533962A5 (enExample) | ||
| CA3052803A1 (en) | Maximizing t-cell memory and compositions and methods therefor | |
| JP2023542528A5 (enExample) | ||
| JP2022543060A5 (enExample) | ||
| JP2022543058A5 (enExample) | ||
| KR20250158012A (ko) | 키메라 항원 수용체 |